Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group
M. Debiec-Rychter, H. Dumez, I. Judson, B. Wasag, J. Verweij, M. Brown, S. Dimitrijevic, R. Sciot, M. Stul, H. Vranck, M. Scurr, A. Hagemeijer, M. Van Glabbeke, A.T. van OosteromVolume:
40
Year:
2004
Language:
english
Pages:
696
DOI:
10.1016/j.ejca.2003.11.025
File:
PDF, 309 KB
english, 2004